Objectives: To evaluate the effect of high-flow oxygen implementation on the respiratory rate as a first-line ventilation support in chronic obstructive pulmonary disease patients with acute hypercapnic respiratory failure.

Conclusions: High-flow oxygen therapy through nasal cannula delivered using high-velocity nasal insufflation was an effective tool for reducing respiratory rate in these chronic obstructive pulmonary disease patients with acute hypercapnic respiratory failure. Early determination and subsequent monitoring of clinical and blood gas parameters may help predict the outcome.

Access Research Journal
Introduction: Until now, no antiviral treatment has been proven to be effective against the COVID-19 virus. The treatment of COVID-19 is symptomatic, and oxygen therapy is recommended by the World Health Organization (WHO) for patients with respiratory distress, hypoxemia, or shock, with a target SpO2 > 94% currently. Timely oxygen therapy, which allows greater levels of oxygen to pass through the thickened and inflamed lung tissue into the bloodstream earlier, can effectively treat hypoxemia. The timing of oxygen therapy, which has rarely been mentioned in the current literature, has a great influence on the symptomatic relief of hypoxemia and seeking medical intervention, especially in situations with limited medical resources.

Conclusions: Early initiation of oxygen therapy was associated with lower mortality among critical patients. This study highlighted the importance of early oxygen therapy after the onset of hypoxia symptoms. Our results also lend support to potentially beneficial effects of IFNα on critical illness.

Access Research Journal
The air we breathe contains approximately 21% oxygen. For most people with healthy lungs, 21% oxygen is sufficient, but if you have chronic obstructive pulmonary disease (COPD) or a condition where your lung function is impaired, the amount of oxygen obtained through normal breathing is not enough. In this case, you'll need supplemental amounts of oxygen to maintain normal body function.

In addition to helping prevent heart failure in people with severe lung diseases, such as COPD, supplemental oxygen has many benefits. According to the American Lung Association, supplemental oxygen improves sleep, mood, mental alertness, and stamina, and allows individuals to carry out normal, everyday functions.

Access Research Journal
Who needs oxygen therapy?
Oxygen therapy is prescribed for people who can’t get enough oxygen on their own. This is often because of lung conditions that prevents the lungs from absorbing oxygen, including:
  • chronic obstructive pulmonary disease (COPD)
  • pneumonia
  • asthma
  • bronchopulmonary dysplasia, underdeveloped lungs in newborns
  • heart failure
  • cystic fibrosis
  • sleep apnea
  • lung disease
  • trauma to the respiratory system
To determine whether a person will benefit from oxygen therapy, doctors test the amount of oxygen in their arterial blood. Another way to check is using a pulse oximeter that indirectly measures oxygen levels, or saturation, without requiring a blood sample. The pulse oximeter clips onto a person’s body part, like a finger. Low levels mean that a person may be a good candidate for supplemental oxygen.


What are the benefits of oxygen therapy?
Oxygen therapy can be extremely beneficial for those who frequently experience low oxygen levels, regardless of the reason. If needed, regularly utilizing oxygen therapy can allow people to be more active and mobile by decreasing shortness of breath. It also can significantly improve quality of life, and in many cases extend life expectancy.

Oxygen therapy can also reduce symptoms such as:
  • headaches 
  • irritability
  • fatigue 
  • swollen ankles
Oxygen therapy can help the growth and development of children who have chronic lung conditions. It can also lessen symptoms such as headaches caused by low oxygen levels, and behavioral changes or problems.

Access Research Journal